Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation

Carbohydrate Polymers

Volumn 98, Issue 1, 2013, Pages 331-340

  Puga, Ana M ^a   Lima, Ana Catarina ^b   Mano, Joao F ^b   Concheiro, Angel ^a   Alvarez Lorenzo, Carmen ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

Chitosan; Colorectal cancer; Pectin; PH responsive release; Skin cancer; Superhydrophobic surfaces

Indexed keywords

BIOMIMETIC PROCESSES; BIOMIMETICS; CELL CULTURE; CELLS; CHEMOTHERAPY; CHITIN; CHITOSAN; DISEASES; GELS; PHASE INTERFACES; SURFACE PROPERTIES;

COLORECTAL CANCER; PECTIN; PH-RESPONSIVE; SKIN CANCERS; SUPER-HYDROPHOBIC SURFACES;

HYDROPHOBICITY;

CHITOSAN; DRUG CARRIER; FLUOROURACIL; GLUTARALDEHYDE; PECTIN; WATER;

ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; COLORECTAL CANCER; GEL; HELA CELL; HUMAN; MICROCAPSULE; ORAL DRUG ADMINISTRATION; PH-RESPONSIVE RELEASE; SKIN CANCER; SUPERHYDROPHOBIC SURFACES; SURFACE PROPERTY;

CHITOSAN; COLORECTAL CANCER; PECTIN; PH-RESPONSIVE RELEASE; SKIN CANCER; SUPERHYDROPHOBIC SURFACES;

ADMINISTRATION, ORAL; CAPSULES; CHITOSAN; DRUG CARRIERS; FLUOROURACIL; GELS; GLUTARAL; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PECTINS; SURFACE PROPERTIES; WATER;

EID: 84879820716     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.05.091     Document Type: Article

References (49)

1. Banna, G. L., Collovà, E., Gebbia, V., Lipari, H., Giuffrida, P., Cavallaro, S., et al. (2010). Anticancer oral therapy: Emerging related issues. Cancer Treatment Reviews, 36, 595-605.
2. Barakat, N. S., & Almurshedi, A. S. (2011). Design and development of glicazideloaded chitosan for oral sustained drug delivery: In vitro/in vivo evaluation. Journal of Microencapsulation, 28, 122-133.
3. Barreiro, R., Coronilla, R., Concheiro, A., & Alvarez-Lorenzo, C. (2005). Preparation of chitosan beads by simultaneous cross-linking/ insolubilisation in basic pH: Rheological optimisation and drug loading/release behaviour. European Journal of Pharmaceutical Sciences, 24, 77-84. (Pubitemid 40051289)
4. Bhat, S. K., Keshavayya, J., Kulkarni, V. H., Reddy, V. K. R., Kulkarni, P. V., & Kulkarni, A. R. (2012). Preparation and characterization of crosslinked chitosan microspheres for the colonic delivery of 5-fluorouracil. Journal of Applied Polymer Science, 125, 1736-1744.
5. Bhattarai, N., Gunn, J., & Zhang, M. (2010). Chitosan-based hydrogels for controlled, localized drug delivery. Advanced Drug Delivery Reviews, 62, 83-99.
6. Ceilley, R. I., & Del Rosso, J. Q. (2006). Current modalities and new advances in the treatment of basal cell carcinoma. International Journal of Dermatology, 45, 489-498.
7. Ciftci, K., & Groves, M. J. (2006). Delivery of antitumor compounds to the rat colon: In vitro and in vivo evaluation. International Journal of Pharmaceutics, 145, 157-164.
8. Das, S., Chaudhury, A., & Ng, K. Y. (2011). Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: Role of chitosan in modifying in vitro and in vivo drug release. International Journal of Pharmaceutics, 406, 11-20.
9. Das, S., & Ng, K. Y. (2010). Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin based formulation. Journal of Pharmaceutical Sciences, 99, 4903-4916.
10. Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011). Chitosan-A versatile semi-synthetic polymer in biomedical applications. Progress in Polymer Science, 36, 981-1014.
11. Evonik. http://eudragit.evonik.com/ Accessed January 2013.
12. Haupt, S., Zioni, T., Gati, I., Kleinstern, J., & Rubinstein, A. (2006). Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancer. European Journal of Pharmaceutical Sciences, 28, 204-211. (Pubitemid 43766100)
13. Jain, A., & Jain, S. K. (2008). In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. European Journal of Pharmaceutical Sciences, 35, 404-416.
14. Jain, A., Jain, S. K., Ganesh, N., Arve, J. B., & Beg, A. M. (2010). Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxiplatin in colorectal cancer. Nanomedicine, 6, 179-190.
15. Kildeeva, N. R., Perminov, P. A., Vladimirov, L. V., Novikov, V. V., & Mikhailov, S. N. (2009). About mechanism of chitosan cross-linking with glutaraldehyde. Russian Journal of Bioorganic Chemistry, 35, 397-407.
16. Kimura, Y., & Okuda, H. (1999). Prevention by chitosan of myelotoxicity gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. Japanese Journal of Cancer Research, 90, 765-774. (Pubitemid 29381107)
17. Kobel, M., Weichert, W., Cruwell, W., Schmitt, W. D., Lautenschlager, C., & Hauptmann, S. (2004). Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Archiv, 445, 456-464. (Pubitemid 39592748)
18. Krishnaiah, Y. S. R., & Khan, M. A. (2012). Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Pharmaceutical Development and Technology, 17, 521-540.
19. Kumar, M. N., Muzzarelli, R. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004). Chitosan chemistry and pharmaceutical perspectives. Chemical Reviews, 104, 6017-6084. (Pubitemid 40025733)
20. Lam, P. L., Lee, K. K. H., Wong, R. S. M., Cheng, G. Y. M., Cheng, S. Y., Yuen, M. C. W., et al. (2012). Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries. Bioorganic & Medicinal Chemistry Letters, 22, 3213-3218.
21. Lim, C. K., Yaacob, N. S., & Halim, A. S. (2010). In vitro biocompatibility of chitosan porous skin regenerating templates (PSRTs) using primary human skin keratinocytes. Toxicology In Vitro, 24, 721-727.
22. Lima, A. C., Custodio, C. A., Alvarez-Lorenzo, C., & Mano, J. F. (2013). Biomimetic methodology to produce polymeric multilayered particles for biotechnological and biomedical applications. Small (in press)
23. Lima, A. C., Song, W., Blanco-Fernandez, B., Alvarez-Lorenzo, C., & Mano, J. F. (2011). Synthesis of temperature-responsive dextran-MA/PNIPAAm particles for controlled drug delivery using superhydrophobic surfaces. Pharmaceutical Research, 28, 1294-1305.
24. Liu, L., Fishman, M. L., Kost, J., & Hicks, K. B. (2003). Pectin-based systems for colonspecific drug delivery via oral route. Biomaterials, 24, 3333-3343. (Pubitemid 36581891)
25. Lunter, D. J., & Daniels, R. (2012). New film forming emulsions containing Eudragit® NE and/or RS 30D for sustained dermal delivery of nonivamide. European Journal of Pharmaceutics and Biopharmaceutics, 82, 291-298.
26. McGillis, S. T., & Fein, H. (2003). Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Seminars in Cutaneous Medicine and Surgery, 23, 174-183.
27. Miura, K., Kinouchi, M., Ishida, K., Fujibuchi, W., Naitoh, T., Ogawa, H., et al. (2010). 5-FU metabolism in cancer and orally-administrable 5-FU drugs. Cancer, 2, 1717-1730.
28. Monteiro, O. A., Jr., & Airoldi, C. (1999). Some studies of crosslinking chitosan-glutaraldehyde interaction in a homogenous system. International Journal of Biological Macromolecules, 26, 119-128. (Pubitemid 29428241)
29. Muzzarelli, R. A. A., Boudrant, J., Meyer, D., Manno, N., Marchis, M., & Paoletti, M. G. (2012). Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate polymers science, on the chitin bicentennial. Carbohydrate Polymers, 87, 995-1012.
30. Neto, A. I., Custodio, C. A., Song, W., & Mano, J. F. (2011). High-throughput evaluation of interactions between biomaterials, proteins and cells using patterned superhydrophobic substrates. Soft Matter, 7, 4147-4151.
31. Paharia, A., Yadav, A. K., Rai, G., Jain, S. K., Pancholi, S. S., & Agrawal, G. P. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech, 8, E87-E93.
32. Paolino, D., Cosco, D., Muzzalipo, R., Trapasso, E., Picci, N., & Fresta, M. (2008). Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. International Journal of Pharmaceutics, 353, 233-242.
33. Pisani, P., Bray, F., & Parkin, D. M. (2002). Estimates of the world wide prevalence of cancer for 25 sites in the adult population. International Journal of Cancer, 97, 72-81.
34. Ruddy, K., Mayer, E., & Partridge, A. (2009). Patient adherence and persistence with oral anticancer treatment. A Cancer Journal for Clinicians, 59, 56-66.
35. Sabitha, M., Sanoj Rejinold, N., Nair, A., Lakshmanan, V. K., Naira, S. V., & Jayakumar, R. (2013). Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydrate Polymers, 91, 48-57.
36. Saw, T. Y., Cao, T., & Ng, M. M. L. (2005). Tooth slide organ culture and established cell line culture models for cytotoxicity assessment of dental materials. Toxicology In Vitro, 19, 145-154. (Pubitemid 39592986)
37. Signini, R., & Campana Filho, S. P. (1999). On the preparation and characterization of chitosan hydrochloride. Polymer Bulletin, 42, 159-166. (Pubitemid 129698848)
38. Singh, B. N., Singh, R. B., & Singh, J. (2005). Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. International Journal of Pharmaceutics, 298, 98-107. (Pubitemid 40828331)
39. Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., et al. (2004). Chitosan microspheres as a potential carrier for drugs. International Journal of Pharmaceutics, 274, 1-33. (Pubitemid 38457003)
40. Song, W., Lima, A. C., & Mano, J. F. (2010). Bioinspired methodology to fabricate hydrogels spheres for multi-applications using superhydrophobic surfaces. Soft Matter, 6, 5868-5871.
41. Sriamornsak, P. (2011). Application of pectin in oral drug delivery. Expert Opinion on Drug Delivery, 8, 1009-1023.
42. Sun, Y., Gu, L., Gao, Y., & Gao, F. (2010). Preparation and characterization of 5- fluorouracil loaded chitosan microspheres by a two-step solidification method. Chemical and Pharmaceutical Bulletin, 58, 891-895.
43. Takara, K., Sakaeda, T., Yagami, T., Kobayashi, H., Ohmoto, N., Horinouchi, M., et al. (2002). Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1- overexpressing derivative cell lines. Biological and Pharmaceutical Bulletin, 25, 771-778. (Pubitemid 40036714)
44. Thakral, N. K., Ray, A. R., & Majumdar, D. K. (2012). Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer. Journal of Materials Science: Materials in Medicine, 21, 2691-2699.
45. Urbanska, A. M., Karagiannis, E. D., Guajardo, G., Langer, R. S., & Anderson, D. G. (2012). Therapeutic effect of orally administered microencapsulated oxiplatin for colorectal cancer. Biomaterials, 33, 4752-4761.
46. Vasiliu, S., Popa, M., & Rinaudo, M. (2005). Polyelectrolyte capsules made of two biocompatible natural polymers. European Polymer Journal, 41, 923-932. (Pubitemid 40305021)
47. Wei, H., Qing, D., De-Ying, C., Bai, X., & Li-Fang, F. (2008). In-vitro and invivo studies of pectin/ethylcellulosefilm-coated pellets of 5-fluorouracil for colonic targeting. Journal of Pharmacy and Pharmacology, 60, 35-44.
48. Yuan, Z., Chen, H., Tang, J., Chen, X., Xhao, D., & Wang, Z. (2007). Facile method to fabricate stable superhydrophobic polystyrene surface by adding ethanol. Surface and Coatings Technology, 201, 7138-7142. (Pubitemid 46547380)
49. Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J. W., & Stamenkovic, I. (1998). Inhibition of tumor growth in vivo by hyaluronan oligomers. International Journal of Cancer, 77, 396-401. (Pubitemid 28299876)